Analyst Ratings for Kalvista Pharmaceuticals Inc (KALV)
KALV Rating Summary
KALV Price Target Summary
- Highest: $38.00 (Jefferies)
- Lowest: $22.00 (Leerink)
- Average: $30.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$30.83 (+14.2%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 61%
Rating Score: 5.8 / 10
Percentile Rank: 61%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Stifel | Paul Matteis | Downgrade | Hold (Buy) |
27.00 (42.00) |
42.00 (27.00) |
-35.71% | Details |
| 5/1/2026 | H.C. Wainwright | Andrew Fein | Downgrade | Neutral (Buy) |
N/A (N/A) |
26.66 (27.00) |
1.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
